• 
• 

Pancreatic Cancer Europe (PCE) is a European multi-stakeholder platform that brings together experts from across Europe, including academics, physicians, politicians, patient groups, patients and other stakeholders, united by a shared commitment to improving outcomes and quality of life for people affected by pancreatic cancer. PCE is based in Brussels and was formally established in 2016 as a non-profit organisation (Belgian ASBL). The platform originated from a Call to Action launched in 2014 at the European Parliament, highlighting the urgent need for a coordinated European response to pancreatic cancer.

Pancreatic Cancer Europe brings together relevant stakeholders to advocate for improvements in the standard of care for patients by addressing gaps in awareness, diagnosis, and research and data collection. Driven by strong political commitment, PCE works through five main workstreams (Awareness, National Support, Registries, Research and Treatment), supported by transversal activities focused on patient and advocate involvement, communication and dissemination, and increased visibility at international level. PCE has a Board of Directors of five members and a growing, validated membership of more than 150 members across EU and non-EU countries, and cooperates closely with key European and international networks active in cancer and gastroenterology.

More information about PCE and its activities is available at:

https://pancreaticcancereurope.eu/